Furthermore, “disease modifying genes” have been recognized, including somatic mutations in ATRX, which mostly co-exist with mutations in SDHB or IDH1/2, with a suggested synergistic effect on tumorigenesis and tumor progression [15,24,25,26]. This evidence concerns the gene SDHB and neoplasm.